Du X,Wen S,Shi R,Xia J,Wang R,Zhang Y .2023 .Peripheral blood lymphocytes di erentiation patterns in responses/ outcomes to immune checkpoint blockade therapies in nonsmall cell lung cancer: A retrospective study. BMC Cancer, 10(1) : 83.
Li P,Qin P,Fu X,Zhang G,Yan X,Zhang M .2021 .Associations between peripheral blood lymphocyte subsets and clinical outcomes in patients with lung cancer treated with immune checkpoint inhibitor. Ann Palliat Med, 10(3) : 3039-49.
Lin X,Chen X,Long X,Zeng C,Zhang Z,Fang W .2023 .New biomarkers exploration and nomogram construction of prognostic and immune-related adverse events of advanced non-small cell lung cancer patients receiving immune checkpoint inhibitors. Respir Res, 10(1) : 64.
Xu X,Wang D,Chen W,Li N,Suwinski R,Rossi A .2021 .A nomogram model based on peripheral blood lymphocyte subsets to assess the prognosis of non-small cell lung cancer patients treated with immune checkpoint inhibitors. Transl Lung Cancer Res, 10(12) : 4511-25.
Yan Y,Wang X,Liu C,Jia J .2022 .Association of lymphocyte subsets with e cacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: A retrospective study. BMCPulm Med, 10(1) : 166.
Uryvaev A,Passhak M,Hershkovits D,Sabo E,Sela GB .2018 .The role of tumor-in ltrating lymphocytes (TILs) as a predictive biomarker of response to anti-PD1 therapy in patients with metastatic non-small cell lung cancer or metastatic melanoma. Med Oncol, 10(3) : 25.